Tirzepatide is a groundbreaking therapeutic agent for individuals battling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://dianehsrp431923.look4blog.com/78385248/tirzepatide-a-novel-glp-1-and-gip-receptor-agonist